Monte Rosa Therapeutics, Inc.

GLUE · Healthcare · Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicin…

Monte Rosa Therapeutics, Inc. (GLUE), in the Healthcare sector, has 15 disclosed filings on Paydirt over the trailing twelve months from 7 corporate insiders: 0 purchases and 15 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Jul 16 and filed Jul 17. The most active filer was Filip Janku with 4 filings.

Add to watchlist

Filings, ttm

0 buys · 15 sells

Traders, ttm

7 insiders

Volume, ttmiDollar value disclosed in the window

$3.3M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Jul 16

Filed Jul 17

ADViAverage daily dollar volume

$21.1M

market data

Share price · 12M

$13.77 (+110.9%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $4.8M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Filip Janku Chief Medical Officer 4 filings MW

Markus Warmuth President & CEO 4 filings AM

Anthony M. Manning Director 2 filings ST

Sharon Townson Chief Scientific Officer 2 filings VP Versant Venture Capital VI, L.P. 10% owner 2 filings JC

Jennifer Champoux Chief Operating Officer 1 filing ED

Edmund Dunn Principal Accounting Officer 1 filing PN

Philip Nickson Chief Business & Legal Officer 1 filing

Recent filings

Markus WarmuthSALE President & CEO $220K
9,500 sh × $23.18
Exec Jul 16
Filed Jul 17 · 4:05 PM ET Jennifer ChampouxSALE Chief Operating Officer $102K
4,351 sh × $23.38
Exec Jul 15
Filed Jul 16 · 4:10 PM ET Sharon TownsonSALE Chief Scientific Officer $130K
5,600 sh × $23.25
Exec Jul 6
Filed Jul 7 · 4:41 PM ET Filip JankuSALE Chief Medical Officer $132K
5,407 sh × $24.50
Exec Jun 30
Filed Jul 1 · 4:57 PM ET Anthony M. ManningSALE Director $231K
10,000 sh × $23.11
Exec Jun 29
Filed Jun 30 · 5:30 PM ET Filip JankuSALE Chief Medical Officer $138K
6,000 sh × $22.95
Exec Jun 29
Filed Jun 30 · 5:30 PM ET Filip JankuSALE Chief Medical Officer $882K
41,845 sh across 2 lots
Exec Jun 23
Filed Jun 25 · 5:30 PM ET Sharon TownsonSALE Chief Scientific Officer $119K
6,000 sh × $19.87
Exec May 29
Filed Jun 1 · 5:30 PM ET Anthony M. ManningSALE Director $180K
10,000 sh × $18.01
Exec May 21
Filed May 22 · 5:30 PM ET Markus WarmuthSALE President & CEO $103K
5,467 sh × $18.92
Exec May 1
Filed May 5 · 5:30 PM ET Markus WarmuthSALE President & CEO $141K
8,000 sh × $17.64
Exec Apr 14
Filed Apr 15 · 5:30 PM ET Philip NicksonSALE Chief Business & Legal Officer $103K
5,845 sh × $17.69
Exec Apr 9
Filed Apr 10 · 5:30 PM ET Edmund DunnSALE Principal Accounting Officer $455K
25,164 sh × $18.10
Exec Feb 27
Filed Mar 2 · 5:30 PM ET Filip JankuSALE Chief Medical Officer $179K
9,189 sh × $19.50
Exec Feb 23
Filed Feb 24 · 5:30 PM ET Markus WarmuthSALE President & CEO $154K
10,135 sh × $15.17
Exec Jan 5
Filed Jan 5 · 5:30 PM ET Versant Venture Capital VI, L.P.SALE 10% owner $1.5M
157,895 sh across 3 lots
Exec Oct 28 2024
Filed Oct 30 2024 · 5:30 PM ET Versant Venture Capital VI, L.P.SALE 10% owner $7.4M
1,132,566 sh × $6.53
Exec Sep 20 2024
Filed Sep 24 2024 · 5:30 PM ET Versant Ventures VI GP, L.P.SALE 10% owner $3.3M
541,897 sh × $6.00
Exec Sep 11 2024
Filed Sep 13 2024 · 5:30 PM ET